300972 Stock Overview
Fujian Wanchen Biotechnology Co., Ltd engages in the research and development, cultivation, production, and sale of edible fungi in China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 6/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Fujian Wanchen Biotechnology Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥32.64 |
| 52 Week High | CN¥40.70 |
| 52 Week Low | CN¥17.69 |
| Beta | 0.084 |
| 11 Month Change | 60.63% |
| 3 Month Change | 33.33% |
| 1 Year Change | -16.73% |
| 33 Year Change | 125.10% |
| 5 Year Change | n/a |
| Change since IPO | 19.56% |
Recent News & Updates
Shareholder Returns
| 300972 | CN Food | CN Market | |
|---|---|---|---|
| 7D | 16.1% | -0.06% | -0.6% |
| 1Y | -16.7% | -22.9% | -21.3% |
Return vs Industry: 300972 exceeded the CN Food industry which returned -20.9% over the past year.
Return vs Market: 300972 exceeded the CN Market which returned -18.8% over the past year.
Price Volatility
| 300972 volatility | |
|---|---|
| 300972 Average Weekly Movement | 8.7% |
| Food Industry Average Movement | 4.8% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 8.9% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 300972's share price has been volatile over the past 3 months.
Volatility Over Time: 300972's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 4,972 | Li Qing Wang | www.vanchen.com |
Fujian Wanchen Biotechnology Co., Ltd engages in the research and development, cultivation, production, and sale of edible fungi in China. It offers flammulina velutipes; and crab-flavored, white jade, seafood mushrooms, etc. The company was founded in 2011 and is based in Zhangpu, China.
Fujian Wanchen Biotechnology Group Co., Ltd. Fundamentals Summary
| 300972 fundamental statistics | |
|---|---|
| Market cap | CN¥5.78b |
| Earnings (TTM) | -CN¥76.42m |
| Revenue (TTM) | CN¥17.99b |
0.3x
P/S Ratio-75.7x
P/E RatioIs 300972 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300972 income statement (TTM) | |
|---|---|
| Revenue | CN¥17.99b |
| Cost of Revenue | CN¥16.19b |
| Gross Profit | CN¥1.80b |
| Other Expenses | CN¥1.88b |
| Earnings | -CN¥76.42m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.43 |
| Gross Margin | 10.03% |
| Net Profit Margin | -0.42% |
| Debt/Equity Ratio | 89.8% |
How did 300972 perform over the long term?
See historical performance and comparison